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Summary
Evidence indicates that androgen-sensitive prostate cancer cells have a lower malignant
potential. We previously demonstrated that expression of androgen receptor (AR) by
transfection of the androgen-independent prostate cancer cell line PC3 decreases invasion
and adhesion of these cells through modulation of a6b4 expression. Treatment with the
androgen further reduced adhesion and invasion of the cells without, however, modifying
a6b4. Here we investigated whether the androgen has a direct effect on a6b4-EGF
receptor (EGFR) interaction and signalling leading to invasion of these cells. Immuno-
confocal microscopy demonstrated that in control cells (PC3-Neo), a6b4 and EGFR
colocalize and redistribute in response to epidermal growth factor (EGF). In PC3-AR cells
colocalization and redistribution between the two molecules was reduced and abolished by
pre-treatment with R1881. Co-immunoprecipitation studies demonstrated that tyrosine
phosphorylation of b4 in response to EGF was reduced in PC3-AR cells compared to PC3-
Neo. Immunoconfocal and co-immunoprecipitation studies demonstrated colocalization
at membrane level and co-immunoprecipitation of EGFR and AR, indicating an
interaction between the two proteins. PI3K activity, a key signalling pathway for invasion
of these cells, was decreased in PC3-AR cells in response to EGF and further reduced by
treatment with R1881. EGFR internalization was strongly reduced in PC3-AR compared
with PC3-Neo cells and was reduced by treatment with R1881. In conclusion, the
expression of AR by transfection in PC3 cells confers a less malignant phenotype by
interfering with EGFR–a6b4 interaction and signalling leading to invasion through a
mechanism involving an interaction between the classic AR and EGFR.
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Introduction
Prostate cancer (PC) is one of the most common
cancers and the second leading cause of death among
other populations than American men only (Amanatullah
et al., 2000). As PC cell growth is enhanced by androgens,
in the advanced stages of the disease androgen ablation
therapy represents a valuable tool for the treatment of
these patients. However, the development in most patients
after few years of treatment of androgen-independent
clones characterized by higher invasiveness and metastatic
properties, has focused attention on the molecular mech-
anisms that lead to loss of androgen dependence as well as
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on the pathways that are regulated by androgens in these
cells. At this stage no valuable tools for the treatment of
the patients are available. Studies performed with patient
specimens have shown that the androgen receptor (AR) is
expressed in almost all cancers of the prostate after
androgen ablation therapy indicating that loss of andro-
gen-dependence is not related to the expression of AR
(Van der Kwast et al., 1993). Indeed, maintenance of
androgen-sensitivity appears to have a more differentiated
and less malignant phenotype of PC cells. The ability to
produce tumours in nude mice, for instance, is higher
in androgen-insensitive cell lines (such as PC3 and
DU145) with respect to the androgen-sensitive (LNCaP)
(Witkowski et al., 1993). Moreover, invasion ability
of androgen-independent prostate carcinoma cells in
response to epidermal growth factor (EGF) is decreased
by transfection with an AR expression vector (Bonaccorsi
et al., 2000; Cinar et al., 2001). In this light, the role of
androgens and AR in the regulation of the signalling
pathways involved in invasion and metastasis represents a
primary task in studies on PC biology. As a result, some
androgen-regulated genes involved in signalling pathways
leading to invasion has been recently identified and their
role in lower invasion ability of androgen-sensitive PC
cells indicated (Bonaccorsi et al., 2000; Sumitomo et al.,
2000; Manos et al., 2001; Trusolino et al., 2001),
suggesting that loss of androgen regulation leads to
increased invasion through multiple pathways.
Multiple pathways resulting from extracellular and intra-
cellular signals regulate invasion of carcinoma cells. Indeed,
cell migration results from merging of signalling pathways,
which employ growth factors and their receptors, adhesion
receptors (integrins) and cytoskeletal elements.
Integrins are heterodimers composed of no covalently
associated alpha and beta subunits (Meredith et al., 1996),
and have a key role in the regulation of proliferation and
invasion of carcinomas (Juliano & Verner, 1993). In
particular, a6b4, one of the main receptors of laminins, is
a primary actor in the process of migration and invasion
(Dans et al., 2001). In normal epithelia a6b4 mediates the
formation of stable adhesive structures termed hemidesmo-
somes, that link intermediate filaments to extracellular
matrix, whereas in carcinoma cells, it promotes migration
on laminin through association with actin cytoskeleton
(Dans et al., 2001). It has been demonstrated that a6b4
co-immunoprecipitates with ErbB-2 and EGF receptor
(EGFR) to promote cell migration and invasion in response
to EGF (Gambaletta et al., 2000; Dans et al., 2001). EGF
stimulates phosphorylation and activation of b4 cyto-
plasmic domain, which leads to phosphoinositide-3 kinase
(PI3K) activation and migration (Gambaletta et al., 2000;
L.Bonaccorsi,V.Carloni,M.Muratori,L.Formigli, S.Zecchi,
C. Forti & E. Baldi, unpublished data). In addition, it has been
recently shown that a6b4 may also represent a functional
amplifier of biochemical signals leading to invasion by
potentiating growth factor activation of Ras- and PI3K-
dependent pathways (Trusolino et al., 2001).
In a previous study we demonstrated that the expression of
a6b4 is higher in androgen-independent prostate carcinoma
cell lines (PC3, DU145) with respect to androgen-sensitive
PC cells, LNCaP and PC3 transfected with a full length hAR
expression vector (PC3-AR) (Bonaccorsi et al., 2000). PC3-
AR cells were characterized by lower binding to laminin-1,
anchorage-independent growth and EGF-mediated invasion
compared with androgen-independent cells (Bonaccorsi et al.,
2000). The treatment with the synthetic androgen R1881
determined a further decrease of the invasion ability of these
cells, without however, modifying the surface expression of
a6b4 (Bonaccorsi et al., 2000) and prospecting an effect of
the androgen on EGF-mediated signalling related to invasion.
In agreement with our results, in a different cell model, Cinar
et al. (2001) have recently demonstrated, that invasion of PC
cells is decreased by transfection with AR and by treatment
with androgens. In order to study if androgens and AR have a
direct effect on EGFR–a6b4 interaction and signalling
leading to invasion in response to EGF, we investigated the
effect of androgens on EGFR–a6b4 interaction, association
of AR with EGFR and PI3K activation leading to invasion in
PC3-AR cells in response to EGF (L. Bonaccorsi, V. Carloni,
M. Muratori, L. Formigli, S. Zecchi, C. Forti & E. Baldi,
unpublished data).
Results
EGFR and a6b4 colocalization in response to EGF
is disrupted in PC3-AR cells
As mentioned above the interaction between EGFR and
a6b4 is essential for carcinoma cell invasion (Mainiero et al.,
1996; Gambaletta et al., 2000). By laser confocal immuno-
fluorescence studies, we demonstrated that a6 and b4
colocalized with the EGFR in basal conditions in PC3-
Neo cells (transfected only with the vector) on laminin-1. In
response to EGF a6, b4 and EGFR redistributed and
colocalized in discrete areas at the level of membrane ruffles.
This pattern of colocalization of a6b4 and EGFR in response
to EGF was not substantially affected by pre-treatment with
androgens. On the contrary, in PC3-AR cells colocalization
between a6, b4 and EGFR was reduced with respect to
PC3-Neo both in basal conditions and in response to EGF.
In addition, pre-treatment with androgens further reduced
redistribution of a6b4 and EGFR suggesting an interference
of AR and androgens with the mechanisms leading to
interaction between the two proteins. Immunoprecipitation
studies conducted on PC3-Neo and PC3-AR cells con-
firmed that this colocalization was caused by an interaction
between a6b4 and EGFR. After immunoprecipitation of
EGFR, b4 was detected in both cell lines and after
immunoprecipitation of b4, EGFR was detected in both
cell lines indicating that the two proteins are constantly
associated in our cell models. By probing the blot with an
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antibody against phosphotyrosine residues we detected a
tyrosine phosphorylated band at 200 kDa exactly migrating
as b4 and a phosphorylated band at 180 kDa corresponding
to EGFR. Tyrosine phosphorylation of both bands increased
in response to EGF in both cell lines, although EGF-induced
tyrosine phosphorylation of b4 was much less evident in
PC3-AR cells. Moreover, in PC3-AR cells autophospho-
rylation of EGFR in response to EGF was lower compared
with PC3-Neo suggesting a reduced activation of EGFR and
b4 integrin subunit by EGF in the presence of the AR.
The androgen receptor colocalizes with EGFR at the plasma
membrane
Recent data indicate that besides its classical localization
at the nuclear level, the AR may be targeted at the
membrane level where interactions with molecules involved
in growth factor signalling, such as src kinase family members
(Migliaccio et al., 2000), caveolin-1 (Lu et al., 2001) and
PI3K (Simoncini et al., 2000) have been demonstrated. We
investigated the localization of AR and EGFR by laser
confocal immunofluorescence experiments. The AR local-
izes both to the nucleus and the cytoplasm of PC3-AR cells,
although after stimulation with androgens, increased location
to the nuclei was evident. Interestingly, a marked colocal-
ization of AR with EGFR at the plasma membrane level was
present. In response to EGF, colocalization between AR and
EGFR was also evident at the level of intracellular granules,
reflecting internalization of the EGFR–AR complex. When
PC3-AR cells were stimulated with EGF in the presence of
androgens, the pattern of colocalization between the two
proteins was different compared with EGF alone because no
discrete granules were present. After immunoprecipitation
with an antibody against EGFR, a band at 110 kDa
corresponding to AR was detected in PC3-AR cells.
Tyrosine phosphorylated bands corresponding to EGFR
and b4 were also detected. Similarly, following immuno-
precipitation of AR in PC3-AR cells, a tyrosine phosphor-
ylated band corresponding to EGFR was also detected.
EGFR and PI-3 kinase are essential for EGF-mediated
invasion in PC3-AR
An association between the EGFR and a6b4 promotes
the activation of several signalling pathways including PI3K
(Shaw, 2001), which finally leads to cell migration and
invasion. To evaluate whether PI3K activation is involved in
Matrigel invasion of PC3-Neo cells, invasion assays were
performed in the absence or presence of the PI3K inhibitor
LY294002. Matrigel invasion in response to EGF was
inhibited by the treatment with LY294002. EGF-mediated
Matrigel invasion was also suppressed by ZD1839 a tyrosine
kinase inhibitor selective for EGFR (Moasser et al., 2001).
To investigate whether PI3K activity was altered in PC3-
AR cells, a PI3K activity assay was performed in both cell
lines. We observed that basal and EGF-stimulated PI3K
activity was reduced in PC3-AR cells with respect to
PC3-Neo. Pre-treatment with androgens determined a
further decrease of EGF-stimulated PI3K activity in
PC3-AR cells, whereas it was ineffective in PC3-Neo cells.
EGFR internalization is reduced in PC3-AR with respect to
PC3-Neo
Recent evidences indicate that a correct endocytotic
pathway is important for EGFR signalling by controlling
the specificity of the response to the agonist (Wiley &
Burke, 2001). It has also been demonstrated that
internalized EGFR is enzymatically active, is still phos-
phorylated and maintains association with many adaptor
proteins (Burke et al., 2001). To investigate whether EGFR
internalization following addition of the growth factor is
affected by androgens, the expression of EGFR on cell
surface by flow cytometry was studied. After EGF
treatment (30 min), a significant decrease in cell surface
expression of the receptor was detected in PC3-Neo cells.
In PC3-AR cells this decrease of EGFR expression was less
marked indicating a decreased internalization. Treatment
with androgens further reduced EGFR internalization in
response to EGF in PC3-AR but did not affect EGFR
internalization in PC3-Neo cells.
Discussion
Androgen-insensitive PC cells are characterized by
increased growth, adhesion, invasion and migration
(Witkowski et al., 1993; Bonaccorsi et al., 2000; Cinar et al.,
2001). We show here that an interaction between AR and
EGFR occurs in androgen-sensitive PC cell lines and
provide evidence that the reduced invasive properties of
these cells are because of a disruption of the interaction
between the EGFR and a6b4, decreased signalling leading
to b4 phosphorylation and lower PI3K activation in response
to EGF. The mechanisms of AR–EGFR interaction as well
as of reduced function of EGFR in PC3-AR cells are not
clear at the moment but it is possible that AR–EGFR
interaction may lead to a sequestration of the EGFR. In fact
our results on EGFR internalization pattern indicate a
disruption of the endocytotic process in PC3-AR cells
compared with parental cells. Recent data have demonstra-
ted that AR is able to interact with plasma membrane-
associated proteins such as src kinase family members
(Migliaccio et al., 2000) and caveolin-1 (Lu et al., 2001)
that is also involved in EGFR signalling by inhibiting EGFR
tyrosine kinase activity. In agreement with these results
caveolin-1 might interact with AR and EGFR mediating a
molecular complex that might negatively regulate invasion
by inhibiting EGFR redistribution, signalling and internal-
ization (see Fig. 1: working hypothesis). In conclusion, in
androgen-sensitive prostate carcinoma cells, androgens and
AR contribute to confer a less malignant phenotype of these
cells both by reducing the expression of a6b4 (Bonaccorsi
et al., 2000) and by interfering with EGFR–a6b4 interaction
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and signalling leading to invasion through an interaction
between AR and EGFR (L. Bonaccorsi, V. Carloni,
M. Muratori, L. Formigli, S. Zecchi, C. Forti & E. Baldi,
unpublished data).
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